Alan P Lombard, Chengfei Liu, Cameron M Armstrong, Leandro S D’Abronzo, Wei Lou, Christopher P Evans, Allen C Gao: Wntless promotes cellular viability and resistance to enzalutamide in castration-resistant prostate cancer cells. Am J Clin Exp Urol 2019;7(4):203-214. (Full text, PDF)
David R Rutkowski, Shane A Wells, Brian Johnson, Wei Huang, David F Jarrard, Joshua M Lang, Steve Cho, Alejandro Roldán-Alzate: Mri-based cancer lesion analysis with 3d printed patient specific prostate cutting guides. Am J Clin Exp Urol 2019;7(4):215-222. (Full text, PDF)
Zhi Wang, Mingming Zhong, Qiong Song, Laura E Pascal, Zhenyu Yang, Zeyu Wu, Ke Wang, Zhou Wang: Anti-apoptotic factor Birc3 is up-regulated by ELL2 knockdown and stimulates proliferation in LNCaP cells. Am J Clin Exp Urol 2019;7(4):223-231. (Full text, PDF)
Qin Gao, Wen-Yee Lee: Urinary metabolites for urological cancer detection: a review on the application of volatile organic compounds for cancers. Am J Clin Exp Urol 2019;7(4):232-248. (Full text, PDF)
Zhenling Duan, Haiyan D Miller, Xiaowei Fu, Dongxia Ge, Ben Jin, Ahmed A Moustafa, Ruoxin Lan, Kun Zhang, Zhenbang Chen, Zongbing You: Th17 cells promote tumor growth in an immunocompetent orthotopic mouse model of prostate cancer. Am J Clin Exp Urol 2019;7(4):249-261. (Full text, PDF)
Jennifer A Stockert, Akriti Gupta, Bryan Herzog, Shalini S Yadav, Ashutosh K Tewari, Kamlesh K Yadav: Predictive value of pseudouridine in prostate cancer. Am J Clin Exp Urol 2019;7(4):262-272. (Full text, PDF)
Qiang Dang, Yu-An Chen, Jer-Tsong Hsieh: The dysfunctional lipids in prostate cancer. Am J Clin Exp Urol 2019;7(4):273-280. (Full text, PDF)
Jonathan J Fox, Héctor I Navarro, Takao Hashimoto, Alejandro J Garcia, Andrew S Goldstein: Mass cytometry reveals species-specific differences and a new level of complexity for immune cells in the prostate. Am J Clin Exp Urol 2019;7(4):281-296. (Full text, PDF)
Rachel K Toth, Jack D Tran, Michelle T Muldong, Eric A Nollet, Veronique V Schulz, Corbin C Jensen, Lori A Hazlehurst, Eva Corey, Donald Durden, Christina Jamieson, Cindy K Miranti, Noel A Warfel: Hypoxia-induced PIM kinase and laminin-activated integrin α6 mediate resistance to PI3K inhibitors in bone-metastatic CRPC. Am J Clin Exp Urol 2019;7(4):297-312. (Full text, PDF)
